Clinical Trial Update: Failure Rate of GLyburide And Metformin Among Gestational Diabetics [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the failure rate of glyburide and metformin in gestational diabetes mellitus has been withdrawn. The study was sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Drugs mentioned

• DiaBeta (glyburide)
• Glucophage (metformin)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Gestational Diabetes Mellitus, Class A2 | Phase 4 | Status: WITHDRAWN